Reactivation of CNV after discontinuation of bevacizumab treatment of age-related macular degeneration

Research output: Contribution to journalArticleResearchpeer-review

Fingerprint

Dive into the research topics of 'Reactivation of CNV after discontinuation of bevacizumab treatment of age-related macular degeneration'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science